Vocabria Tablet, Film Coated
Product Images NDC 49702-248

2 FDA label images from Viiv Healthcare Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vocabria (NDC 49702-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cabotegravir Sodium Chemical Structure (Vocabria Spl Graphic 01)

Cabotegravir Sodium Chemical Structure (Vocabria Spl Graphic 01)
Chemical structure diagram of cabotegravir sodium, the active ingredient in Vocabria 30 mg oral tablets by ViiV Healthcare Company.*
FDA Label Image

Vocabria 30 mg Tablet 30 Count Label (Vocabria Spl Graphic 02)

Vocabria 30 mg Tablet 30 Count Label (Vocabria Spl Graphic 02)
The label for Vocabria (cabotegravir) 30 mg film-coated tablets by ViiV Healthcare displays product details including strength, dosage form, and quantity of 30 tablets. It includes safety instructions, storage conditions, manufacturer information, and a barcode. The label also highlights an alert about medicines that should not be taken with Vocabria.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.